Cannabis Law Report

DECEMBER 2, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. Prescription Medicine. Prescription Medicine.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

DECEMBER 4, 2019

In this article, Dr. Snyder distills her analysis of hemp testing during the 2018 and 2019 growing seasons. Based on her data, Dr. Snyder finds that requiring “Total THC” concentrations not to exceed 0.3%, rather than just limiting ?9-THC, THCA is a non-psychoactive cannabinoid found in higher concentrations in cannabis plants.

Data 59

Data THC Strains Concentrates 59

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Today, databases, predictive analytics, artificial intelligence , and machine learning are having widespread effects on cannabis businesses, investors, regulators, and consumers. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Why Do MMJ Patients Use Cannabis? How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

JANUARY 7, 2022

According to a recent report published in JAMA Pediatrics , the number of adolescents who reported vaping cannabis within the previous 30 days has increased substantially since 2013—specifically, from 1.6% After the 2019 vape crisis that resulted in at least 68 deaths across the U.S., Time for Modern Approaches to Cannabis.

Vaping 98

Vaping Education Data Consumption 98

Cannabis Law Report

JULY 19, 2021

The cannabis industry has gone through many series of events that has brought it to the billion dollar industry it is today. Since its move from the illicit market, to the legalization of medicinal cannabis in 1996, and continued positive shifts of perceptions of cannabis, there has been exponential growth in the industry.

Medicine 105

Medicine Programs Data Events 105

Veriheal

MAY 18, 2023

Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. The team peered into the findings of numerous articles published between 2001 and 2019.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Cannabis Law Report

NOVEMBER 10, 2019

Exclusive data collaboration between The Green Fund and Freshleaf Analytics. In April 2019, QLD amended their patient access process making it easier for doctors to write prescriptions. Record growth continues. It’s worth remembering how far the Australian market has come in just the last 12 months.

Access 45

Access Medicine Data Patients 45

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 11, 2019

This report provides an analysis of the latest data on the drug situation and responses to it across the European Union, Norway and Turkey. It is supported by other, online information resources, including our Statistical Bulletin, containing source data. Introduction – Cannabis Highlighted ( By CLR).

Medicine 40

Medicine Data THC Policy 40

Cannabis Law Report

JULY 13, 2021

As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. This is what they are saying. Mapping Psychedelic Drug Policy Reform. A number of U.S.

Decriminalization 105

Decriminalization Legalization Data Safety 105

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

The Cannigma

FEBRUARY 24, 2022

Our bodies have a built-in framework ready to accept the active molecules in cannabis, like THC. This could lead one to believe we might actually be “hardwired” to consume cannabis, but this is not actually the case. Moreover cannabis has been used medicinally and recreationally for thousands of years.

Cannabinoids 128

Cannabinoids Research and Development Conditions Cannabis 128

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 109

Consumption Patients Research and Development Data 109

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Parkinson’s disease and cannabis. Interest among patients is high, but knowledge is limited.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

MAY 21, 2022

Cannabis Therapeutica. New record for Portugal : in 2021 cannabis exports increased by 600% compared to 2020 and for 2022 the forecasts are rosy. . Portugal among the new protagonists of the European cannabis market. Portugal among the new protagonists of the European cannabis market. Here are all the details.

Decriminalization 52

Decriminalization Cultivation Data Cannabis 52

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Cannabis Law Report

NOVEMBER 20, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. All other cannabis-based medicines are unlicensed. Read the full story.

Clinical Trials 45

Clinical Trials Data Medicine Patients 45

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

FEBRUARY 12, 2020

Two Perth-based cannabis companies are set to make their debut on the ASX in the coming days, hoping to revitalise an industry that has seen better days. Dr Winlow told AAP that companies have been putting too much effort into growing pot and not enough into proving the drug is a safe and effective medicine.

Medicine 59

Medicine Data Patients Oil 59

Cannabis Law Report

FEBRUARY 14, 2020

Cannabis Wire report. Saint Vincent and the Grenadines is targeting increased foreign investment in the country’s fledgling medical cannabis industry in an effort to diversify its economy away from its weak exports of traditional crops and goods. million in tax revenue and licensing fees in 2019, far outpacing the US $1.8

Banking 59

Banking Medicine Data Cultivation 59

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge.

Education 101

Education Clinical Trials Medicine Policy 101

The Cannigma

AUGUST 31, 2021

In China, cannabis is largely viewed negatively and recreational use is completely banned. Under the PRC Criminal Law, cannabis is legally classified as being equivalent to heroin, opium, morphine and cocaine. However, cannabis and the cannabis industry still has a large presence in China. is a resounding no.

Legalization 69

Legalization Cultivation Hemp Medicine 69

Kind Meds (Cannabis Education Blog)

MARCH 9, 2022

Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. And with the growing legalization of cannabis, there is often more space for parents to smoke weed without fear of legal consequences. Kansas journal of medicine, 13, 129–130. 1] Burggren, A.

Digestion 98

Digestion Consumption Cannabis Recreational 98

The Blunt Truth

MAY 6, 2021

Two bipartisan cannabis research bills start their legislative journey. The Texas legislature moves on cannabis decriminalization. cannabis research bills. A bipartisan, bicameral group recently introduced the VA Medicinal Cannabis Research Act. The Supreme Court refuses to hear a 280E case. supreme court.

Decriminalization 111

Decriminalization State Laws Collective CBD 111

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. One of the proposed bills would amend the Cannabis Control Law during the current 150-day Diet session, which launched on Monday, January 23.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

SpeedWeed

AUGUST 22, 2021

A report released by the MS Society states that not nearly enough medical cannabis patients have been able to obtain medical cannabis through the National Health Service (NHS), despite research and firsthand accounts of its effectiveness as a medicine for MS patients. I didn’t realize how tough it was until it stopped.”.

Sleep 52

Sleep Access Patients Treatment 52

Cannabis Law Report

JUNE 26, 2019

Minister for Health Simon Harris TD today signed legislation which will allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years. The Programme will facilitate access to cannabis-based products for medical use in line with legislation. We have highlighted relevant passages.

Medicine 55

Medicine Access Business Legislation 55

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. ” Dr. Gallow prides himself on his work as a South African cannabis advocate and leader in the international medical cannabis research field. It has been fairly slow,” explained Dr. Gallow.

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

Cannabis Law Report

SEPTEMBER 15, 2019

The full media report dated 30 August 2019 can be found at. Medizinisches Cannabis bringt dem Staat Millionen. million tax revenues through cannabis as medicine. million euros in tax revenues with medicinal cannabis in 2018. These data are based on an extrapolation of the top pharmacist association.

Media 45

Media Medicine Collective Data 45

Cannabis Law Report

SEPTEMBER 3, 2019

Prohibition Partners is proud to launch The North American Cannabis Report , the most in-depth industry report focused on the Canadian and US cannabis markets. Although the US is currently the most profitable cannabis industry in the world, the model is imperfect. billion by 2024. Here’s the report’s key findings.

Environment 45

Environment Data Consumption Medicine 45

Cannabis Law Report

JANUARY 23, 2022

I was a young cannabis research student on my first trip overseas to an international research conference. Events like these afford us a glimpse into the future of research and medicine in this field. The field of transplantation in medicine will see developments over the next decades that resemble something from a sci-fi documentary.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Veterans can expect to find conflicting information regarding the efficacy of cannabis for their PTSD.

Treatment 104

Treatment Sleep Clinical Trials Data 104

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

SpeedWeed

AUGUST 31, 2021

Missouri did not launch medical cannabis sales until Oct. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. Including Missouri, 21 states implemented medical cannabis laws since 2005, according to DHSS.

Programs 72

Programs Patients Dispensary Cultivation 72

Cannabis Law Report

SEPTEMBER 5, 2019

Sep 5, 2019. patent to protect its technology used to track the cultivation, classification, and identification of cannabis seeds and plants. Cannabis producers will be able to secure the integrity of their products by monitoring their origin and final use. Information is power, data is power.”. Author: Rebecca Lee Katz.

Supply Chain 45

Supply Chain Seed-To-Sale Data Medicine 45

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105